Ribosomal protein L21 pseudogene 128 (RPL21P128)

Ribosomal protein L21 pseudogene 128 (RPL21P128) is not a protein-coding gene; it is a pseudogene related to the ribosomal protein L21 (RPL21)[4][1]. Ribosomal protein L21 itself is a structural component of the 60S large ribosomal subunit, essential for protein synthesis in eukaryotes[5][7][3]. However, pseudogenes like RPL21P128 do not produce functional protein—they are unexpressed or functionally inactive copies or remnants of formally active genes and typically do not have a known direct role in biology or disease, nor are they considered therapeutic targets[4][7]. There are multiple pseudogenes for RPL21 across the genome, but none are recognized as receptors, enzymes, targets, or direct disease drivers[4][6][7]. RPL21P128 is not considered a therapeutic target (is_target is false) and is unlikely to be a therapeutically relevant target or a molecule of pharmacological interest (is_incorrect is true). Information for pseudogenes related to biological function, disease role, drugs, or biomarkers is generally absent or irrelevant[4][7]. In summary, RPL21P128 is a non-functional pseudogene related to ribosomal protein L21, present in the genome without evidence of protein expression or direct biological/clinical relevance as a target. The canonical, functional protein is "Ribosomal protein L21" (RPL21), which is distinct from its pseudogenes[4][5][7].

Other names

RPL21_62_1585RPL21P128